About the Authors
- Luis Alberto García Rodríguez
* E-mail: firstname.lastname@example.org
Affiliation Centro Español de Investigación Farmacoepidemiológica (CEIFE), Madrid, Spain
- Antonio González-Pérez
Affiliations Centro Español de Investigación Farmacoepidemiológica (CEIFE), Madrid, Spain, Departamento de Genómica Estructural, Neocodex SL, Sevilla, Spain
- Héctor Bueno
Affiliation Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
- John Hwa
Affiliation Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America
I have read the journal's policy and have the following conflicts: CEIFE has received unrestricted research grants from Bayer and Pfizer in the last five years. Dr. Bueno reports having received consulting fees from Almirall, Bayer, BMS, and Sanofi-Aventis, and research grants from Astra-Zeneca, BMS, and Pfizer. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.
Conceived and designed the experiments: LAGR AG-P. Performed the experiments: LAGR AG-P. Analyzed the data: LAGR AG-P JH. Wrote the paper: LAGR AG-P JH HB.